trade name of tirzepatide Users Zepbound or Mounjaro Had Lower Blood Pressure in Study Tirzepatide (Mounjaro) In Sherman Oaks
Description
-- ( categories) Diabetes codes are combination codes that include: * (Type 1, Type 2, due to drug, due to another disease, etc.) * () (kidney, eye, neuropathy, etc.) * (with/without hyperglycemia or hypoglycemia) 1 Diabetes due to underlying condition Drug or chemical-induced diabetes Type 1 diabetes mellitus Type 2 diabetes mellitus Other specified diabetes mellitus 2 1
Retatrutide (LY3437943) is an investigational triple GLP-1, GIP, and glucagon receptor agonist developed by Eli Lilly, with Phase 2 clinical data published in 2023 showing dose-dependent body weight reductions and HbA1c improvements
Tirzepatide dosing follows a specific escalation protocol designed to minimize side effects while building tolerance
Call (800) 937-8443 for a free evaluation!
Most insurance accepted
Explore tirzepatide weight loss Houston options tailored for lasting results
